| pharmacoeconomics |
Study of the cost-benefit ratios of drugs with other therapies or with similar drugs, where costs include both financial and quality-of-life measures Phase I study: The first of the four phases of clinical trials, Phase I studies are designed to establish the effects of a new drug in humans. These studies are usually conducted in small numbers of healthy volunteers to determine a drug's toxicity, absorption, distribution, and metabolism.
출처: www.dcri.duke.edu/patient/glossary.jsp
|
|---|---|
| pharmacoeconomics |
The branch of economics that applies cost-benefit, cost-effectiveness, cost-minimization, and cost-utility analyses to compare the economics of different pharmaceutical products or to compare drug therapy to other treatments. Sometimes referred to as outcomes research. Source: Applied Clinical Trials/Advanstar. Click for their site: www.advanstar. ...
출처: www.biotechmedia.com/definitions-p.html
|